Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Carolyn Riley"'
Publikováno v:
Medicine Access @ Point of Care, Vol 5 (2021)
Introduction: Physicians in the United States play an essential role guiding patients through single patient pre-approval access (PAA) to investigational medical products via either the Food and Drug Administration (FDA)’s Expanded Access (EA) or t
Externí odkaz:
https://doaj.org/article/51cc7330963b40d482a62c0373c527c2
Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs
Publikováno v:
Ethics & Human Research, 2020 Jan 01. 42(1), 2-13.
Externí odkaz:
https://www.jstor.org/stable/26913725
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chapman, Carolyn Riley
Publikováno v:
Journal of Community Genetics; Oct2023, Vol. 14 Issue 5, p441-452, 12p
Autor:
Carolyn Riley Chapman
Advances in genomics have enabled the development of polygenic scores (PGS), sometimes called polygenic risk scores, in the context of multifactorial traits and diseases such as height, cancer, cardiovascular disease, and mental illness. PGS are meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::060e399c5018466ae355dc26a06040ea
https://doi.org/10.21203/rs.3.rs-2022716/v1
https://doi.org/10.21203/rs.3.rs-2022716/v1
Autor:
Carolyn Riley, Chapman
Publikováno v:
Journal of community genetics.
Advances in genomics have enabled the development of polygenic scores (PGS), sometimes called polygenic risk scores, in the context of multifactorial diseases and disorders such as cancer, cardiovascular disease, and schizophrenia. PGS estimate an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af58d6ab95ec5a04d5bca5475cbbb36c
https://pubmed.ncbi.nlm.nih.gov/36529843
https://pubmed.ncbi.nlm.nih.gov/36529843
Autor:
Chapman, Carolyn Riley1 Carolyn.Chapman@nyulangone.org, Folkers, Kelly McBride1, McFadyen, Andrew2, Shah, Lesha D.1, Bateman-House, Alison1
Publikováno v:
American Journal of Bioethics. Jun2019, Vol. 19 Issue 6, p22-25. 4p.
Autor:
Carolyn Riley Chapman
Publikováno v:
The American Journal of Bioethics. 20:W1-W3
Back in 1978, Louise Brown made international headlines simply for being born, the first to do so after in vitro fertilization (IVF). One ethicist acknowledged fears that IVF “might move us toward ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5142bede116f17e209688f8680d03b93
https://doi.org/10.1080/15265161.2020.1820112
https://doi.org/10.1080/15265161.2020.1820112
Publikováno v:
AMA Journal of Ethics. 21:E1021-1028
Hundreds of gene therapies are currently in various stages of research and development. A subset of these involve gene editing technologies such as CRISPR. In this hypothetical case, a patient with chronic pain has initiated a CRISPR-based interventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be33e3b47c2f423af03d5e5d62d123a
https://doi.org/10.1001/amajethics.2019.1021
https://doi.org/10.1001/amajethics.2019.1021
Autor:
Lesha D. Shah, Kelly McBride Folkers, Carolyn Riley Chapman, Andrew McFadyen, Alison Bateman-House
Publikováno v:
The American Journal of Bioethics. 19:22-25
Preapproval nontrial access, historically called “compassionate use,” and certain off-label usage of approved medical products are two forms of innovative practice, defined by Earl as a situation “...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4516c5249e17bfd446dcc9f0a9761c0a
https://doi.org/10.1080/15265161.2019.1602191
https://doi.org/10.1080/15265161.2019.1602191